Patents by Inventor Vance P. Lemmon

Vance P. Lemmon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KLF family members regulate intrinsic axon regeneration ability
    Patent number: 8609617
    Abstract: This invention relates, to a method for promoting CNS axon regeneration, comprising (1) inhibiting the expression or activity in a neuron of one or more of the members of the Krüppel-like transcription factor (KLF) family that suppress axon growth (e.g., KLF 1, 2, 3, 4, 5, 9,12, 13, 14, 15 and/or 16), and/or (2) stimulating the expression or activity in a neuron of one or more of the members of the KLF family that promote axon growth (e.g., KLF 6 and/or 7).
    Type: Grant
    Filed: September 7, 2010
    Date of Patent: December 17, 2013
    Assignee: University of Miami
    Inventors: Jeffrey L. Goldberg, Vance P. Lemmon, John Bixby, Darcie Moore, Murray Blackmore
  • KLF FAMILY MEMBERS REGULATE INTRINSIC AXON REGENERATION ABILITY
    Publication number: 20120225084
    Abstract: This invention relates, e.g., to a method for promoting CNS axon regeneration, comprising (1) inhibiting the expression or activity in a neuron of one or more of the members of the Krüppel-like transcription factor (KLF) family that suppress axon growth (e.g., KLF 1, 2, 3, 4, 5, 9, 12, 13, 14, 15 and/or 16), and/or (2) stimulating the expression or activity in a neuron of one or more of the members of the KLF family that promote axon growth (e.g., KLF 6 and/or 7).
    Type: Application
    Filed: September 7, 2010
    Publication date: September 6, 2012
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Jeffrey L. Goldberg, Vance P. Lemmon, John Bixby, Darcie Moore, Murray Blackmore
  • SUBSTITUTED TRIAZINE COMPOUNDS FOR NERVE REGENERATION
    Publication number: 20100239500
    Abstract: A family of substituted triazine compounds is synthesized by combinatorial solid phase chemistry. These compounds were found to increase the growth of neurons/axons from central nervous system neurons that had been damaged, and can be used in methods and pharmaceutical compositions for treating injuries, diseases and conditions associated with nerve damage.
    Type: Application
    Filed: March 31, 2008
    Publication date: September 23, 2010
    Inventors: John L. Bixby, Vance P. Lemmon, Young-Tae Chang, Jae-Wook Lee, Jaeki Min, Lynn Usher